000 01627 a2200433 4500
005 20250516184123.0
264 0 _c20150202
008 201502s 0 0 eng d
022 _a1432-198X
024 7 _a10.1007/s00467-013-2696-0
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRuebner, Rebecca L
245 0 0 _aNephrotic syndrome associated with tyrosine kinase inhibitors for pediatric malignancy: case series and review of the literature.
_h[electronic resource]
260 _bPediatric nephrology (Berlin, Germany)
_cMay 2014
300 _a863-9 p.
_bdigital
500 _aPublication Type: Case Reports; Journal Article
650 0 4 _aAdolescent
650 0 4 _aAntineoplastic Agents
_xadverse effects
650 0 4 _aChild
650 0 4 _aFemale
650 0 4 _aGlioma
_xcomplications
650 0 4 _aHumans
650 0 4 _aInfant
650 0 4 _aLeukemia, B-Cell
_xcomplications
650 0 4 _aLeukemia, Myeloid, Acute
_xcomplications
650 0 4 _aMale
650 0 4 _aNeoplasms
_xcomplications
650 0 4 _aNephrotic Syndrome
_xchemically induced
650 0 4 _aPrecursor Cell Lymphoblastic Leukemia-Lymphoma
_xcomplications
650 0 4 _aProtein Kinase Inhibitors
_xadverse effects
650 0 4 _aProtein-Tyrosine Kinases
_xantagonists & inhibitors
700 1 _aCopelovitch, Lawrence
700 1 _aEvageliou, Nicholas F
700 1 _aDenburg, Michelle R
700 1 _aBelasco, Jean B
700 1 _aKaplan, Bernard S
773 0 _tPediatric nephrology (Berlin, Germany)
_gvol. 29
_gno. 5
_gp. 863-9
856 4 0 _uhttps://doi.org/10.1007/s00467-013-2696-0
_zAvailable from publisher's website
999 _c23341166
_d23341166